CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Revenue:
Total revenue	$ 2,049,107	$ 3,828,326
Cost of revenue:
Total cost of revenue	415,268	649,007
Gross profit	1,633,839	3,179,319
Operating expenses:
Research and development costs	705,981	659,940
Selling and marketing	1,189,846	1,396,640
General and administrative	849,939	837,867
Restructuring costs	744	302,313
Total operating expenses	2,746,510	3,196,760
Operating income (loss)	(1,112,671)	(17,441)
Gain on debt extinguishment	0	754,000
Interest and other expense	(117,995)	(283,648)
Income (loss) before income taxes	(1,230,666)	452,911
Income tax expense (benefit)	(121,260)	44,616
Net income (loss)	(1,109,406)	408,295
Less: Accrual of Series A redeemable convertible preferred stock dividends	300,921	277,170
Less: Accretion to redemption value of Series A redeemable convertible preferred stock	14,815	197,114
Net income (loss) attributable to common stockholders	$ (1,425,142)	$ (65,989)
Basic net income (loss) per share attributable to common stockholders	$ (0.20)	$ (0.01)
Diluted net income (loss) per share attributable to common stockholders	$ (0.20)	$ (0.01)
Weighted average basic shares outstanding	7,082,276	5,949,463
Weighted average diluted shares outstanding	7,082,276	5,949,463
Product revenue
Revenue:
Total revenue	$ 594,928	$ 2,139,729
Cost of revenue:
Total cost of revenue	20,719	222,834
Support and services revenue
Revenue:
Total revenue	1,454,179	1,688,597
Cost of revenue:
Total cost of revenue	$ 394,549	$ 426,173